RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$69.94M	-
CEO	Shah Gaurav	778.3K	$2.84M	-
COO	Stevens Christopher James	554.1K	$2.02M	-
Other	Patel Kinnari	441.9K	$1.61M	-
Dir	Makker Gotham	395.9K	$1.44M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 14, 2025	Schwartz Jonathan David70	See Remarks	Sell	11,161	$3.02	$33,695.06	-4.7%	+8.9%	-
Aug 14, 2025	Militello John71	See Remarks	Sell	7,043	$3.02	$21,262.82	-11.0%	+8.9%	-
Aug 14, 2025	Wilson Martin86	General Counsel	Sell	12,109	$3.02	$36,557.07	-8.1%	+8.9%	-
Jul 3, 2025	Ondrey Aaron	Chief Financial Officer	Sell	1,477	$2.88	$4,256.71	-1.1%	+9.0%	-
May 20, 2025	Militello John71	See Remarks	Sell	357	$6.45	$2,301.22	-0.6%	-55.8%	-
May 20, 2025	Schwartz Jonathan David70	See Remarks	Sell	801	$6.45	$5,163.25	-0.3%	-55.8%	-
May 20, 2025	Patel Kinnari67	See Remarks	Sell	767	$6.45	$4,944.08	-0.2%	-55.8%	-
May 20, 2025	Shah Gaurav69	CEO	Sell	2,253	$6.45	$14,522.84	-0.3%	-55.8%	-
May 20, 2025	Wilson Martin86	General Counsel	Sell	587	$6.45	$3,783.80	-0.4%	-55.8%	-
May 16, 2025	Militello John71	See Remarks	Sell	655	$6.53	$4,275.84	-1.0%	-53.4%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC